Spironolactone is associated with reduced risk of new-onset atrial fibrillation in patients receiving renal replacement therapy.
about
Spironolactone is associated with reduced risk of new-onset atrial fibrillation in patients receiving renal replacement therapy.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Spironolactone is associated w ...... ing renal replacement therapy.
@en
Spironolactone is associated w ...... ing renal replacement therapy.
@nl
type
label
Spironolactone is associated w ...... ing renal replacement therapy.
@en
Spironolactone is associated w ...... ing renal replacement therapy.
@nl
prefLabel
Spironolactone is associated w ...... ing renal replacement therapy.
@en
Spironolactone is associated w ...... ing renal replacement therapy.
@nl
P50
P1476
Spironolactone is associated w ...... ing renal replacement therapy.
@en
P2093
Jiunn-Lee Lin
Yi-Wei Chung
P304
P356
10.1016/J.IJCARD.2015.05.167
P407
P50
P577
2015-05-31T00:00:00Z